MedPath

Effect of Omega-3 fatty acids on premenstrual syndrome

Phase 3
Conditions
Premenstrual syndrome.
Premenstrual tension syndrome
Registration Number
IRCT138808122624N2
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
123
Inclusion Criteria

Age between 20-45, educational status of more than diploma, regular & normal menstruation, BMI= 19-26, and having premenstrual syndrome.
Exclusion criteria: pregnancy and lactation, primary and secondary amenorrhea, any history of psychological disorders, any drug use, using contraceptive pills, allergy to omega-3, history of coagulopathy, and using food supplements, history of dramatic events like marriage, death of relatives and surgery during last 3 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Somatic sign of premenstrual syndrome. Timepoint: 1.5 and 3 months later. Method of measurement: questionnare.;Psychiatric sign of premenstrual syndrome. Timepoint: 1.5 & 3 months. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath